GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Euroapi SA (LTS:0EAP) » Definitions » Total Stockholders Equity

Euroapi (LTS:0EAP) Total Stockholders Equity : €983.6 Mil (As of Dec. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Euroapi Total Stockholders Equity?

Euroapi's Total Stockholders Equity for the quarter that ended in Dec. 2024 was €983.6 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Euroapi's Book Value per Share for the quarter that ended in Dec. 2024 was €10.33. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Euroapi's Debt-to-Equity for the quarter that ended in Dec. 2024 was 0.07.


Euroapi Total Stockholders Equity Historical Data

The historical data trend for Euroapi's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Euroapi Total Stockholders Equity Chart

Euroapi Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Total Stockholders Equity
Get a 7-Day Free Trial 989.40 1,015.90 1,110.20 927.80 983.60

Euroapi Semi-Annual Data
Dec19 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Total Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,110.20 1,193.10 927.80 889.60 983.60

Euroapi  (LTS:0EAP) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Euroapi's Book Value per Share for the quarter that ended in Dec. 2024 is

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Euroapi's Debt-to-Equity for the quarter that ended in Dec. 2024 is

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Euroapi Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Euroapi's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


Euroapi Business Description

Traded in Other Exchanges
Address
15 rue Traversiere, Paris, FRA, 75012
Euroapi SA develops, manufactures, markets, and distributes Active Pharmaceutical Ingredients (APIs) and Intermediates used in the formulation of medicines for human and veterinary use, both from originators, generics, and cosmetics. The company offers vitamin B12, prostaglandins, oligonucleotides, peptides, corticoids and hormones, anti-infectives, opiates (morphine, codeine, thebaine, etc.), analgesics, etc. It also offers Contract Development Manufacturing Organization (CDMO) services to its customers. Geographically, the company generates maximum revenue from Europe, followed by North America, Asia-Pacific, and the Rest of the world.

Euroapi Headlines

No Headlines